Your browser doesn't support javascript.
loading
Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months.
Pelliccia, Maria; Andreozzi, Patrizia; Paulose, Jayson; D'Alicarnasso, Marco; Cagno, Valeria; Donalisio, Manuela; Civra, Andrea; Broeckel, Rebecca M; Haese, Nicole; Jacob Silva, Paulo; Carney, Randy P; Marjomäki, Varpu; Streblow, Daniel N; Lembo, David; Stellacci, Francesco; Vitelli, Vincenzo; Krol, Silke.
Afiliação
  • Pelliccia M; European School of Molecular Medicine (SEMM), IFOM-IEO-Campus, via Adamello 16, Milan 20139, Italy.
  • Andreozzi P; Università degli Studi di Milano, Milan 20122, Italy.
  • Paulose J; Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, IFOM-IEO-campus, via Adamello 16, Milan 20139, Italy.
  • D'Alicarnasso M; Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, IFOM-IEO-campus, via Adamello 16, Milan 20139, Italy.
  • Cagno V; Instituut-Lorentz for theoretical physics, Leiden University, 271, Niels Bohrweg 2, NL 2333 CA Leiden, The Netherlands.
  • Donalisio M; European School of Molecular Medicine (SEMM), IFOM-IEO-Campus, via Adamello 16, Milan 20139, Italy.
  • Civra A; Università degli Studi di Milano, Milan 20122, Italy.
  • Broeckel RM; Fondazione CEN-European Centre for Nanomedicine, Piazza Leonardo da Vinci, 32, 20133 Milan, Italy.
  • Haese N; Laboratory of Molecular Virology and Antiviral Research, Department of Clinical and Biological Sciences, University of Turin, S. Luigi Gonzaga Hospital, Regione Gonzole 10, 10043 Orbassano, Italy.
  • Jacob Silva P; Laboratory of Molecular Virology and Antiviral Research, Department of Clinical and Biological Sciences, University of Turin, S. Luigi Gonzaga Hospital, Regione Gonzole 10, 10043 Orbassano, Italy.
  • Carney RP; Laboratory of Molecular Virology and Antiviral Research, Department of Clinical and Biological Sciences, University of Turin, S. Luigi Gonzaga Hospital, Regione Gonzole 10, 10043 Orbassano, Italy.
  • Marjomäki V; Vaccine &Gene Therapy Institute, Oregon Health &Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, USA.
  • Streblow DN; Vaccine &Gene Therapy Institute, Oregon Health &Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, USA.
  • Lembo D; Institute of Materials and Interfaculty Bioengineering Institute, École polytechnique fédérale de Lausanne, STI IMX SUNMIL MXG 030, Station 12, CH-1015 Lausanne, Switzerland.
  • Stellacci F; Institute of Materials and Interfaculty Bioengineering Institute, École polytechnique fédérale de Lausanne, STI IMX SUNMIL MXG 030, Station 12, CH-1015 Lausanne, Switzerland.
  • Vitelli V; Department of Biological and Environmental Science/Nanoscience Center, University of Jyväskyla, Survontie 9, 40500 Jyväskyla, Finland.
  • Krol S; Vaccine &Gene Therapy Institute, Oregon Health &Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, USA.
Nat Commun ; 7: 13520, 2016 11 30.
Article em En | MEDLINE | ID: mdl-27901019
ABSTRACT
Up to 80% of the cost of vaccination programmes is due to the cold chain problem (that is, keeping vaccines cold). Inexpensive, biocompatible additives to slow down the degradation of virus particles would address the problem. Here we propose and characterize additives that, already at very low concentrations, improve the storage time of adenovirus type 5. Anionic gold nanoparticles (10-8-10-6 M) or polyethylene glycol (PEG, molecular weight ∼8,000 Da, 10-7-10-4 M) increase the half-life of a green fluorescent protein expressing adenovirus from ∼48 h to 21 days at 37 °C (from 7 to >30 days at room temperature). They replicate the known stabilizing effect of sucrose, but at several orders of magnitude lower concentrations. PEG and sucrose maintained immunogenicity in vivo for viruses stored for 10 days at 37 °C. To achieve rational design of viral-vaccine stabilizers, our approach is aided by simplified quantitative models based on a single rate-limiting step.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estabilidade de Medicamentos / Excipientes / Vacinas contra Adenovirus / Imunogenicidade da Vacina Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estabilidade de Medicamentos / Excipientes / Vacinas contra Adenovirus / Imunogenicidade da Vacina Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália